AKTX:NASDAQ
Akari Therapeutics PLC
$9.16
arrow_downward
-7.24%(-0.72) 1D
$9.38
arrow_upward
+2.40% (+0.22)bedtimeAfter hours
Closed: Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
$9.63
High
$10.12
Low
$9.16
Mkt. cap
17.83M
Avg. vol.
82.14K
Volume
63.65K
52-wk high
$49.60
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
Open
$9.63
High
$10.12
Low
$9.16
Mkt. cap
17.83M
Avg. vol.
82.14K
Volume
63.65K
52-wk high
$49.60
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
Akari Therapeutics (AKTX) Climbs 5.84% to $7.79, Testing Key Resistance at $8.18 - Butterfly Setup
CarePlus VietNam
·
1 month ago
Akari Therapeutics (AKTX) Slips 2.76% as Stock Tests Support Near $8.04 - Strong Buy Stocks
CarePlus VietNam
·
2 months ago
Akari Therapeutics Q1 2026 Earnings: EPS Miss Widens as Pre-Revenue Biotech Faces Headwinds - Earnings Cycle Report
CarePlus VietNam
·
2 months ago
Akari Therapeutics (AKTX) Edges Higher by 1.57%, Testing Near-Term Resistance at $14.29 - OBV Divergence
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com